1. National Institute for Health and Care Excellence . Cardiovascular disease: risk assessment and reduction, including lipid modification (CG1818) [online], 2016. Available: https://www.nice.org.uk/guidance/cg181 [Accessed 8 July 2022].
2. National Institute for Health and Care Excellence . Clinical Knowledge Summaries lipid modification - CVD prevention [online], 2020. Available: https://cks.nice.org.uk/topics/lipid-modification-cvd-prevention/ [Accessed 8 Jul 2022].
3. NHS England . Summary of national guidance for lipid management [online], 2022. Available: https://www.england.nhs.uk/aac/publication/summary-of-national-guidance-for-lipid-management/ [Accessed 8 Jul 2022].
4. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
5. National Institute for Health and Care Excellence . Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia (TA385) [online], 2016. Available: https://www.nice.org.uk/guidance/ta385 [Accessed 18 May 2022].